Blaj S, Piso P. Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?. Curr. Issues Pharm. Med. Sci. 2018;30(4):207-210. doi:10.1515/cipms-2017-0040